To hear about similar clinical trials, please enter your email below
Trial Title:
Respiratory Training and Relaxation Techniques to Improve Adjuvant Radiation Therapy in DIBH in Breast Cancer
NCT ID:
NCT05975190
Condition:
Radiotherapy
Breast Cancer
Relaxation
Breathholding
Conditions: Official terms:
Breast Neoplasms
Conditions: Keywords:
Adjuvant radiotherapy for Breast Cancer
DIBH in left sided Breast Cancer
Respiratory and Relaxation Techniques
patients compliance
active participation under radiotherapy
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Intervention model description:
The randomized design of the study will test R&R interventions compared to current
conventional DIBH instruction.
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
Description:
R&R training provided on an MP3-player for daily practice
Arm group label:
R&R arm (interventional arm)
Summary:
The goal of this prospective clinical trial is to improve patient compliance and
performance of deep inspiration breath hold (DIBH) to further reduce the cardiac dose
from left breast radiation, and to improve cooperation and patient satisfaction through
an active and formal pre-treatment respiratory training program combined with relaxation
training (R&R) in breast cancer patients undergoing adjuvant radiotherapy for left sided
breast cancer.
The main questions the study aims to answer are:
- Does the use of communication training and the use of relaxation techniques (R&R)
reduce the Maximum dose to the heart (Dmax) and improve further heart dose
parameters in deep inspiration during adjuvant radiotherapy for breast cancer?
- Does R&R improve longitudinal anxiety and quality of life under patients undergoing
DIBH adjuvant radiotherapy for left sided breast cancer?
Participants will be randomly assigned to either an experimental arm, which will receive
the R&R, versus a standard arm that will not receive the R&R.
- training program in the experimental arm includes breath hold training, music, and
nature sounds that patients can listen to on an MP3 player
- both groups complete standardized questionnaires about their well-being and
satisfaction at prospective time points before, during the radiation treatment
course, as well as at 6 weeks follow-up
Researchers will compare the R&R group (interventional arm) to current conventional DIBH
instruction (standard group) to see if Dmax to the heart decreases and compliance and
satisfaction under patients rises.
Detailed description:
Postoperative radiotherapy is widely practiced and highly effective in enabling breast
conserving therapy in early stage tumors, and decreasing recurrence while improving
survival in patients with advanced-stage breast cancer, the most common cancer in women.
However, these benefits of radiotherapy are associated with a long-term risk of cardiac
morbidity and mortality in breast cancer survivors. The unintended cardiac radiation
exposure due to the heart's proximity to the treatment target has been well recognized,
particularly in left-sided breast cancer. Because there is no lowest "safe" threshold
radiation dose level for radiation-induced cardiac complications, the dose to the heart
must be kept as low as possible to reduce the complications risk.
Recent advances in high-precision 3D conformal and intensity-modulated radiotherapy
techniques have enabled better protection of the heart. Treatment in deep inspiration
breath hold (DIBH) is indispensable to realize these technological capabilities by taking
advantage of the greater distance created between the radiotherapy target and the
contralaterally and inferiorly displaced heart during deep inspiration. While many
studies have demonstrated reduction of the heart dose with DIBH, challenges in decreasing
heart dose to a minimum remain.
Radiotherapy in DIBH requires active and complex cooperation from the patient, and its
success critically depends on how well patients are capable to perform the prolonged
extended deep breathing maneuver on a repetitive basis every day during their weeks-long
treatment course. Both the physical demands and profound anxiety and stress, which are
highly prevalent in breast cancer patients, additionally interfere with patients' DIBH
performance. Anxiety is well known to directly adversely affect breathing patterns,
thereby challenging patients' ability to perform DIBH optimally.
Preliminary research explored the role of physical training and showed that targeted DIBH
training improves patients' cooperation and the ease of the DIBH procedure, and reduces
the radiation dose to the heart. However, while DIBH training regimens may improve
patients' physical respiratory skill levels, they do not address their mental stress and
anxiety. Relaxation techniques to alleviate anxiety and stress have been rarely used in
complex radiotherapy procedures, particularly not in DIBH. Preliminary studies in
diagnostic radiology procedures suggest that advanced communication and relaxation
techniques, targeted to relieve anxiety and stress, improve patients' procedural
performance, anxiety and comfort. The investigators hypothesize that implementing both,
DIBH Respiratory Training and advanced communication and Relaxation Training (R&R),
improve patients' DIBH performance skills and further reduce heart dose, while
alleviating anxiety and stress and improving quality of life during and after radiation
therapy.
The investigators propose to test this hypothesis in a clinical trial randomizing R&R vs.
standard-of-care management in patients with radiotherapy in DIBH for left breast cancer.
The investigators primary endpoint will assess heart dose (Dmax), and secondary endpoints
include longitudinal anxiety and quality of life assessment and clinic workflow
efficiency. The ultimate goal of this proposal is to develop a validated patient-centered
training and integrative health regimen to further improve the success of
advanced-technology-based cardiac dose reduction, and improve cardiac health in breast
cancer survivors.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Female breast cancer patients
- Left sided breast cancer
- Treated with surgery prior to radiotherapy
- Age >18 years at time of inclusion
- WHO performance status 0-1
- Planned for radiotherapy alone to the breast, the chest wall and/or the lymph node
areas
- Radiotherapy based on planning-CT scan using either 3D-CRT, IMRT, or VMAT/RapidArc
- Written Informed consent
Exclusion Criteria:
- Age <18 years
- Pregnancy, Breastfeeding
- Previous thoracic or mediastinal radiation
- Bilateral breast cancer
- Partial breast irradiation
- M1 disease (metastatic breast cancer)
- Severe lung disease
Gender:
Female
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Department of Radiation Oncology, Technical University of Munich
Address:
City:
Munich
Zip:
81675
Country:
Germany
Status:
Recruiting
Contact:
Last name:
Kai Borm, MD
Phone:
0049-89-4140-4501
Email:
kai.borm@mri.tum.de
Contact backup:
Last name:
Rebecca Asadpour, MD
Phone:
0049-89-4140-4501
Email:
rebecca.asadpour@mri.tum.de
Start date:
June 22, 2022
Completion date:
December 31, 2025
Lead sponsor:
Agency:
Technical University of Munich
Agency class:
Other
Collaborator:
Agency:
German Cancer Aid
Agency class:
Other
Source:
Technical University of Munich
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05975190